COVID-19 Vaccines and Thrombosis—Roadblock or Dead-End Street?

COVID-19 Vaccines and Thrombosis—Roadblock or Dead-End Street?

Two adenovirus-based vaccines, ChAdOx1 nCoV-19 and Ad26.COV2.S, and two mRNA-based vaccines, BNT162b2 and mRNA.1273, have been approved by the European Medicines Agency (EMA), and are invaluable in preventing and reducing the incidence of coronavirus disease-2019 (COVID-19). Recent reports have poin...

Full description

Bibliographic Details
Main Authors: Kenneth Lundstrom, Debmalya Barh, Bruce D. Uhal, Kazuo Takayama, Alaa A. A. Aljabali, Tarek Mohamed Abd El-Aziz, Amos Lal, Elrashdy M. Redwan, Parise Adadi, Gaurav Chauhan, Samendra P. Sherchan, Gajendra Kumar Azad, Nima Rezaei, Ángel Serrano-Aroca, Nicolas G. Bazan, Sk Sarif Hassan, Pritam Kumar Panda, Pabitra Pal Choudhury, Damiano Pizzol, Ramesh Kandimalla, Wagner Baetas-da-Cruz, Yogendra Kumar Mishra, Giorgio Palu, Adam M. Brufsky, Murtaza M. Tambuwala, Vladimir N. Uversky
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Biomolecules
Subjects:
COVID-19
vaccines
SARS-CoV-2
thrombosis
chronic smokers
Online Access:https://www.mdpi.com/2218-273X/11/7/1020

Internet

https://www.mdpi.com/2218-273X/11/7/1020

Similar Items